ROMEO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 3.279
AS - Asia 1.180
NA - Nord America 719
SA - Sud America 211
AF - Africa 21
Totale 5.410
Nazione #
RU - Federazione Russa 2.572
US - Stati Uniti d'America 693
SG - Singapore 421
IT - Italia 324
CN - Cina 302
BR - Brasile 173
IE - Irlanda 172
HK - Hong Kong 145
VN - Vietnam 96
KR - Corea 81
DE - Germania 64
JP - Giappone 58
IN - India 36
FR - Francia 28
GB - Regno Unito 23
NL - Olanda 23
AR - Argentina 21
AT - Austria 19
FI - Finlandia 13
MX - Messico 12
ZA - Sudafrica 10
CA - Canada 7
EC - Ecuador 7
ID - Indonesia 7
PK - Pakistan 7
GR - Grecia 6
BD - Bangladesh 5
ES - Italia 5
IQ - Iraq 5
SE - Svezia 5
CZ - Repubblica Ceca 4
EG - Egitto 4
PL - Polonia 4
CO - Colombia 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
TR - Turchia 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 5.410
Città #
Moscow 885
Singapore 211
Dublin 170
Hong Kong 143
Santa Clara 135
Naples 99
Hefei 90
Seoul 81
Ashburn 69
Chandler 59
Beijing 45
New York 43
Ho Chi Minh City 36
Dallas 34
Bengaluru 29
Boardman 24
Munich 21
Hanoi 20
São Paulo 18
Amsterdam 17
Los Angeles 17
Rome 17
Boydton 13
Bremen 13
Nuremberg 13
Vienna 12
Paris 11
Princeton 11
Caserta 10
Roxbury 10
Viterbo 10
Cambridge 9
Salerno 9
The Dalles 9
Aversa 7
Falkenstein 7
Tokyo 7
Belo Horizonte 6
Sennori 6
Turku 6
Brasília 5
Curitiba 5
Da Nang 5
Des Moines 5
Frankfurt am Main 5
Mexico City 5
Milan 5
Atlanta 4
Brooklyn 4
Cesa 4
Hải Dương 4
Johannesburg 4
Lappeenranta 4
Manassas 4
Sialkot 4
Tianjin 4
Warsaw 4
Bisaccia 3
Buffalo 3
Chennai 3
Chicago 3
Guayaquil 3
Helsinki 3
Jacksonville 3
Lima 3
London 3
Medford 3
Ninh Bình 3
Padova 3
Porto Alegre 3
Rio de Janeiro 3
Stockholm 3
Zola Predosa 3
Albanella 2
Arnhem 2
Baghdad 2
Baku 2
Barcelona 2
Bari 2
Bishkek 2
Boston 2
Brno 2
Brussels 2
Bắc Ninh 2
Cabo Frio 2
Cairo 2
Cape Town 2
Caracas 2
Casoria 2
Catania 2
Caxias 2
Clifton 2
Columbus 2
Contagem 2
Eldorado do Sul 2
Forlì 2
Fortaleza 2
Guangzhou 2
Haiphong 2
Itajaí 2
Totale 2.609
Nome #
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 161
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 144
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 141
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 140
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 135
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 135
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 129
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 126
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 124
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 124
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 123
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 120
Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study 116
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 113
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 110
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 110
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 109
INTESTINAL MICROBIOTA, INTESTINAL PERMEABILITY AND THE UROGENITAL TRACT: IS THERE A PATHOPHYSIOLOGICAL LINK? 108
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 108
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 108
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 107
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 107
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 107
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 106
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 102
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 101
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 101
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 96
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 95
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 94
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 94
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 94
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 92
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 91
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 88
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 87
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 86
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 85
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 85
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 85
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 84
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 83
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 82
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 81
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 81
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 80
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 78
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 76
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 74
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 71
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 67
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 64
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic 64
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 64
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 59
Totale 5.495
Categoria #
all - tutte 16.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 2 6 3 7 10 17 5
2021/2022110 0 6 6 14 15 9 1 0 5 4 27 23
2022/2023348 17 9 6 20 75 17 2 14 156 9 13 10
2023/2024323 19 11 24 29 55 58 9 9 5 10 31 63
2024/2025804 22 16 16 38 119 92 105 91 95 65 81 64
2025/20263.841 209 346 264 183 420 2.419 0 0 0 0 0 0
Totale 5.495